Join us for the 6th edition of this engaging hybrid conference. The ILCS will offer insights into the latest breakthroughs and developments in lung cancer treatment. This conference will harness digital platforms to foster meaningful engagement and networking opportunities for attendees from medical offices, universities, and institutes, allowing them to connect with esteemed medical oncologists and industry professionals at the forefront of lung cancer treatment and research. With distinguished speakers from the USA, Spain, UK, Italy, Netherlands, France, Austria, and Switzerland, the ILCS promises to be an invaluable platform for sharing knowledge and advancing seamless treatment practices.